Vanguard Capital Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $209K | Buy |
1,883
+4
| +0.2% | +$443 | 0.21% | 100 |
|
2025
Q1 | $211K | Buy |
+1,879
| New | +$211K | 0.26% | 93 |
|
2021
Q3 | – | Sell |
-3,313
| Closed | -$228K | – | 163 |
|
2021
Q2 | $228K | Sell |
3,313
-5,563
| -63% | -$383K | 0.17% | 129 |
|
2021
Q1 | $582K | Buy |
+8,876
| New | +$582K | 0.5% | 50 |
|
2020
Q2 | $297K | Buy |
+3,862
| New | +$297K | 0.35% | 77 |
|
2019
Q4 | $360K | Sell |
5,542
-379
| -6% | -$24.6K | 0.38% | 80 |
|
2019
Q3 | $375K | Buy |
+5,921
| New | +$375K | 0.44% | 74 |
|